Clark Estates Inc. NY lessened its holdings in shares of John Wiley & Sons, Inc. (NYSE:WLY – Free Report) by 7.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 88,700 shares of the company’s stock after selling 7,100 shares during the quarter. John Wiley & Sons accounts for approximately 0.8% of Clark Estates Inc. NY’s holdings, making the stock its 19th largest holding. Clark Estates Inc. NY owned 0.16% of John Wiley & Sons worth $4,280,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Glenmede Trust Co. NA increased its holdings in shares of John Wiley & Sons by 40.0% in the third quarter. Glenmede Trust Co. NA now owns 7,489 shares of the company’s stock worth $361,000 after acquiring an additional 2,139 shares in the last quarter. D.A. Davidson & CO. acquired a new position in shares of John Wiley & Sons in the 3rd quarter valued at approximately $2,134,000. The Manufacturers Life Insurance Company increased its stake in John Wiley & Sons by 9.5% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 21,138 shares of the company’s stock worth $1,020,000 after purchasing an additional 1,830 shares in the last quarter. Westfield Capital Management Co. LP raised its holdings in John Wiley & Sons by 1.8% during the 3rd quarter. Westfield Capital Management Co. LP now owns 201,767 shares of the company’s stock worth $9,735,000 after buying an additional 3,481 shares during the period. Finally, Cerity Partners LLC lifted its stake in John Wiley & Sons by 84.6% in the third quarter. Cerity Partners LLC now owns 15,760 shares of the company’s stock valued at $760,000 after buying an additional 7,222 shares in the last quarter. 73.94% of the stock is currently owned by institutional investors.
Insider Buying and Selling at John Wiley & Sons
In related news, EVP Danielle Mcmahan sold 2,318 shares of the firm’s stock in a transaction on Tuesday, October 8th. The shares were sold at an average price of $49.41, for a total value of $114,532.38. Following the completion of the transaction, the executive vice president now owns 8,978 shares of the company’s stock, valued at approximately $443,602.98. This trade represents a 20.52 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.62% of the company’s stock.
John Wiley & Sons Stock Down 0.0 %
John Wiley & Sons (NYSE:WLY – Get Free Report) last announced its earnings results on Thursday, September 5th. The company reported $0.47 earnings per share for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.08). The company had revenue of $403.81 million during the quarter, compared to analyst estimates of $387.40 million. John Wiley & Sons had a positive return on equity of 21.59% and a negative net margin of 6.00%. John Wiley & Sons’s revenue for the quarter was down 10.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.27 earnings per share.
John Wiley & Sons Cuts Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, October 24th. Investors of record on Tuesday, October 8th were given a $0.352 dividend. This represents a $1.41 dividend on an annualized basis and a yield of 2.65%. The ex-dividend date of this dividend was Tuesday, October 8th. John Wiley & Sons’s dividend payout ratio is presently -70.50%.
John Wiley & Sons Company Profile
John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.
Recommended Stories
- Five stocks we like better than John Wiley & Sons
- How to Plot Fibonacci Price Inflection Levels
- 2 Generic Drug Stocks Ready to Surge in 2025
- What is the S&P/TSX Index?
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
- How Technical Indicators Can Help You Find Oversold StocksĀ
- 2 Essential Data Center Solutions Providers Riding the AI Boom
Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.